Find trials
Search tips

A Study Of Wearable Technologies To Track CRF In HF

Overview

About this study

The purpose of this study is the validation of a multimodal wearable patch for estimating and tracking CRF in HF patients to advance remote HF management by enabling proactive intervention to delay disease progression and improve the quality and length of patients’ lives.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18-80 years of age will participate in this study. Individuals with a clinical diagnosis of HF with reduced ejection fraction (ejection fraction <40%) who are undergoing clinical CPET as part of their routine clinical care.

 

Exclusion Criteria:

  • The inability to exercise, the presence of a ventricular-assist device, or.HF patients with preserved ejection fraction (HFpEF) will not be included in this study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/29/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Courtney Wheatley-Guy, Ph.D.

Contact us for the latest status

Contact information:

Rebekah McCoy

4803016021

mccoy.rebekah@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20598473

Mayo Clinic Footer